SAN DIEGO, April 20 A new report from KLAS, an independent health care vendor research firm, concluded the CareFusion (NYSE: CFN) Alaris® System is one of the "best all-around" infusion pump options ...

BD is recalling hundreds of thousands of its Alaris infusion pumps and vital sign monitors due to multiple system faults, including software- and user-related issues. According to the FDA, the errors ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company (BDX), a New Jersey-based medical ...

PEORIA — On any given day, nurses provide compassionate, and, often, life-saving care to their patients. Sometimes that care can have a worldwide impact because of how health care — and those who work ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...

This technological achievement takes patient care and safety to a new level. ATLANTA, March 21, 2017 /PRNewswire-USNewswire/ -- Grady is proud to be Metro Atlanta's first hospital to successfully ...

(RTTNews) - Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S. Securities and Exchange Commission to resolve an ...

CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).